(Q37857545)

24 August 2017

1 reference

title

The changing epidemiology of HIV-infected patients in the intensive care unit (English)

1 reference

24 August 2017

0 references

0 references

1 reference

1 reference

Kristina Crothers

3

0 references

author name string

Kathleen M Akgün

series ordinal

1

1 reference

PubMed ID

21436170

24 August 2017

Margaret Pisani

series ordinal

2

1 reference

PubMed ID

21436170

24 August 2017

language of work or name

1 reference

24 March 2011

1 reference

Journal of Intensive Care Medicine

24 August 2017

1 reference

24 August 2017

26

1 reference

24 August 2017

3

1 reference

24 August 2017

151-164

1 reference

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

24 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Estimating the proportion of patients infected with HIV who will die of comorbid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Increased COPD among HIV-positive compared to HIV-negative veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Critical care of immunocompromised patients: human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Current issues in critical care of the human immunodeficiency virus-infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Outcomes of intensive care for patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Outcome of intensive care in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Aetiology and prognostic factors of patients with AIDS presenting life-threatening acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Is HIV involved in the pathogenesis of non-infectious pulmonary complications in infected patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Role of human immunodeficiency virus in primary pulmonary hypertension--case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Predictive ability of acute physiology and chronic health evaluation II scoring applied to human immunodeficiency virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Adrenal pathology in the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

The use of ketoconazole as an inhibitor of steroid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Adrenal insufficiency in critically ill patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Gastrointestinal hemorrhage in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Lung cancer in patients with HIV infection: is it AIDS-related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Elevated risk of lung cancer among people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Elevated incidence of lung cancer among HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Non-AIDS-defining cancer in HIV-infected people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Central nervous system infections in individuals with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Mycobacterium avium complex lymph node abscess after use of highly active antiretroviral therapy in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Lactic acidosis complicating the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Steatosis-lactic acidosis syndrome associated with stavudine and lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

Intensive Care of Patients with HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066610387996

21 January 2018

Identifiers

DOI

10.1177/0885066610387996

1 reference

24 August 2017

1 reference

PubMed ID

21436170